Delivery Order SPE2DB22D1106-SPE2DB24FFMT3
Award Date
9/12/24
Potential Completion Date
9/13/24
Potential Value
$71K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of Glimepiride 4 mg tablets to the Defense Logistics Agency (DLA), a defense agency under the U.S. Department of Defense. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor, that is a subsidiary of the parent company Cencora, Inc. The contract, identified as SPE2DB20D1051|SPE2DB24FD6WW, has a ceiling value of $3,622.41 and is a Firm Fixed Price Delivery Order contract. The ultimate completion date is February 1,...
This federal contract award is for the delivery of Glimepiride 4 mg tablets to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $5,327.63 and an ultimate completion date of December 7, 2023. It is a firm fixed-price delivery order contract, and there is no set-aside designation. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., which...
This federal contract award is for the delivery of GLIMEPIRIDE 4 MG TABLET 100S to the Defense Logistics Agency (DLA), a defense agency. The contract has a ceiling value of $10,717.42 and is a firm fixed-price delivery order. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider headquartered in Conshohocken, Pennsylvania. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug...
This federal contract award is for the delivery of 4 mg Glimepiride tablets to the Defense Logistics Agency (DLA). The $7,283.48 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on November 22, 2024. The contract has an ultimate completion date of November 25, 2024 and is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division was issued by the Defense Logistics Agency (DLA) Troop Support Medical, a major command within the U.S. Department of Defense. The contract, valued at up to $1,723.02, is for the delivery of Glimepiride 4 mg tablets. This award is a Delivery Order under an existing Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA, worth up to $999,999,999.00 through December 2025. The IDC serves as...
This federal contract award is for the delivery of Glimepiride 4 mg tablets to the U.S. Defense Logistics Agency (DLA) Troop Support Medical. The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, which is a leading global pharmaceutical distribution company. The award is a firm fixed price delivery order with a ceiling value of $2,223.48 and an ultimate completion date of March 27, 2024. No set-aside designation was used for this contract....
This federal contract award is for the delivery of GLIMEPIRIDE 4 MG TABLET 100S to the Defense Logistics Agency (DLA), a defense agency. The contract, valued at $9,286.57, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of January 21, 2025. This award is not associated with a set-aside designation, indicating open competition....
This federal contract award is for the delivery of 4,564,931,294 units of the drug Glimepiride 1 mg tablets, with a ceiling value of $4,046.78, awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a...
This federal contract award is for the delivery of GLIMEPIRIDE 4 MG TABLET 100S, a generic prescription drug, to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for a ceiling value of $4,218.99. The contract has an ultimate completion date of April 3, 2025 and was awarded on April 2, 2025. This contract is a delivery order under an Indefinite Delivery Contract (IDC) that Amerisourcebergen holds...
This federal contract award is for the delivery of GLIMEPIRIDE 4 MG TABLET 100S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on December 16, 2024, with a ceiling value of $4,433.73 and a completion date of December 17, 2024. The contract is a Firm Fixed Price Delivery Order with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite...